Mitochondrial Membrane Intracellular Communication in Healthy and Diseased Myocardium

Introduction

Mitochondria are paramount for energy production in all tissues, especially in highly energetic organs such as the heart. In the myocardium, mitochondria compose around 30% of the total cell volume and synthesize 6 kg of ATP per day via oxidative phosphorylation (Vásquez-Trincado et al., 2016). Mitochondria also have extensive interactive networks with many organelles within the cell, most notably the endoplasmic reticulum (ER). Through these interactions, the mitochondrion also influence Ca²⁺ signaling, reactive oxygen species (ROS), and cell death (Szymański et al., 2017).

Although cardiac disease death rate since the 1950s has substantially declined, it is still the leading cause of mortality among American adults (National Center for Health Statistics, 2018). According to the 2018 National Health Interview Survey, 11.2% of adults in the United States are affected by cardiac diseases, with heart failure (HF) being the most common diagnosis (National Center for Health Statistics, 2018). In 2014, there were 1.1 million emergency department visits with HF as the primary cause and 4.1 million visits with HF as comorbidity. The direct medical costs of HF in 2012 were estimated to be $30.7 billion, with a projected increase to $69.7 billion by 2030 (Jackson et al., 2018). Globally, in 2017, cardiovascular disease was indicated as the cause of nearly 18 million deaths contributing to approximately 330 million years of life lost. These deaths represent a 21.1% increase over the previous decade (Roth et al., 2018).

The expansion of cardiac disease burden is partly due to increased life expectancy and a partial understanding of contributing factors that promote cardiac pathology. Despite the significant amount of research being performed in this area, treatment strategies for many types of cardiac diseases, including HF, remain limited. This review will discuss mitochondrial dynamics, mitochondria and ER roles in cardiac physiology, and therapeutic interventions that focus on mitochondrial and ER stress.

Importance of Mitochondrial Dynamics, Ultrastructure, and Morphology in Cardiac Physiology

The mitochondrion is a double membrane organelle composed of an outer membrane, intermembrane space, inner membrane, and matrix. The inner mitochondrial membrane exhibits complex folding to increase functional surface area confined within the outer mitochondrial membrane. The electron transport chain, ATP synthase, and many other mitochondrial membrane proteins are localized within the inner mitochondrial membrane (Zick et al., 2009). In yeast and certain mammalian cells, ER tubules constrict the mitochondria prior to the recruitment of proteins involved in mitochondria dynamics (Friedman et al., 2011). Unlike non-cardiac mitochondria, mitochondria in the adult heart are partially immobile, possessing restricted capacity to move and distribute in cytoplasmic tubular networks (Ong et al., 2017). Indeed, continuous mitochondrial networks can span the length of the cell both in the transverse and longitudinal directions. These networks function to exchange cristae components and substrates (Franzini-Armstrong, 2007; Picard et al., 2015). The presence of mitochondrial nanotunnels in cardiomyocytes, but not in skeletal muscle, suggests a direct mode of communication between cardiac mitochondria across distances up to several microns. These nanotunnels contain an outer membrane as well as cristae and therefore allow the sharing of matrix components (Huang et al., 2013; Eisner et al., 2017; Lavorato et al., 2017). Due to limited mitochondrial movement in the myocardium, this mode of communication has been implicated in ensuring content sharing in the absence of proximal direct contact. These structures have been visualized both by live-cell confocal imaging (Huang et al., 2013) and electron microscopy (Lavorato et al., 2017). Indeed, cardiac nanotunnels appear to have distinct spatiotemporal dynamics compared to other mitochondrial contacts in terms of formation, transport, and structures formed (Huang et al., 2013). The role of mitochondria nanotunnels in cardiac pathologies remain to be fully characterized.

Mitochondria in adult cardiomyocytes are divided into three groups based on their location and function: interfibrillar, subsarcolemmal, and perinuclear (Palmer et al., 1977). Interfibrillar mitochondria comprise most of the mitochondrial population and are found between myofibrils. They have tubular cristae that are involved in ATP production for cardiomyocyte contraction and Ca²⁺ signaling. Subsarcolemmal mitochondria are located under the sarcolemmal membrane and have lamellar cristae used for energy generation for ion channels and cell signaling (Riva et al., 2005; Ong et al., 2017). Perinuclear mitochondria are clustered around the sides of the nucleus and are postulated to aid in transcriptional regulation (Santel and Fuller, 2001; Ong et al., 2017). These different types of mitochondria are all functionally linked, thus participating in electrical conduction coupling among cardiac cells (Amchenkova et al., 1988).

Mitochondrial ultrastructure and dynamics are integral for cardiac tissue maintenance and homeostasis. Cardiac pathophysiological conditions have been linked to alterations in these processes and include swelling, loss or reorientation of cristae, distortion of configuration, or vacuoles found in the inner or outer compartments (Hoppel et al., 2009). Of note, cardiac pathologies have been linked to the presence of giant mitochondria. The clearance of dysfunctional mitochondria is a significant component in mitochondrial network health and involves a process known as mitophagy (Galluzzi et al., 2017). Giant mitochondria can be formed by either fusion of two mitochondria via increased expression of mitofusins (Mfn) or by the growth of a single mitochondrion (Kraus and Cain, 1980; Arbustini et al., 1998; Santel and Fuller, 2001). However, the mechanism of how giant mitochondria directly participate in cardiac dysfunction remains largely understudied. Mitochondrial morphology is regulated by fission and fusion (Figure 1), a balanced process required for a healthy cell.

Mitochondrial fission is used in repair, cell division, and mitophagy, while fusion is used to elongate and exchange matrix components. Dysregulation of these processes is observed in various cardiovascular pathologies and linked to disease progression (Vásquez-Trincado et al., 2016). Fission is regulated by GTPases mitochondrial fission 1 protein (Fis1), dynamin-related protein 1 (Drp1), mitochondrial fission factor (Mff), and mitochondrial dynamic proteins of 49 and 51 kDa (MiD49/51). These outer mitochondrial membrane proteins act as receptors for Drp1 and work to recruit Drp1 to the mitochondria as Drp1 lacks a mitochondrial targeting sequence (Gandre-Babbe and Van Der Bliek, 2008; Losón et al., 2013). They are potentially redundant as each receptor can interact with Drp1 independently; nevertheless, it remains unclear whether these receptors compete or work in consortium in the overall process (Yu et al., 2020). It is reported that in 293T cells, MiD49/51 and Mff may compete with each other to interact with Drp1 (Yu et al., 2017). The importance of Fis1 in translocating Drp1 to the mitochondria remains controversial. Studies have reported that knockout of human Fis1 (hFis1) in HeLa and HCT116 cells does not affect Drp1 binding to the mitochondria (Lee et al., 2004; Otera et al., 2010), while another study using mouse embryonic stem cells reported that Fis1 is heavily involved in recruiting Drp1 to the mitochondria—potentially more than Mff (Seo et al., 2020).

The importance of mitochondrial fission has been highlighted by studying how the downregulation of Drp1 causes mitochondrial elongation, hindrance of mitophagy, increased probability for mitochondrial permeability transition pore (mPTP) opening, and altered stress responses. Genetic mouse models of Drp1 downregulation developed cardiac dysfunction and possessed increased susceptibility for ischemia/reperfusion (I/R) injury (Ikeda et al., 2015). Moreover, mitochondrial fission helps cell repair by extruding damaged components, which is then targeted for removal and degradation via mitophagy. Drp-1-mediated fission has been shown to act as an adaptive mechanism during cellular stress, although its role in exercise is debatable. One study found Drp1-mediated fission in mice to amplify cardiac and mitochondrial function during exercise (Coronado et al., 2018). A more recent study also performed in mice found fission mediated by Mcl-1—a potential receptor for Drp1—to reduce nutrient deprivation-induced cell death but, on the other hand, reduce mitochondrial ability to adapt to a sudden increase in energy demand and workload (Moyzis et al., 2020). As a balanced regulation of fission is necessary for healthy cells, overexpression of Drp1 also induced mitochondrial dysfunction and excessive cell death in the cardiomyocytes via apoptosis (Ikeda et al., 2015).

Drp1 is extensively regulated by many posttranslational mechanisms, including phosphorylation of residues Ser-637 and Ser-616. Phosphorylation of Ser-616 activates Drp1, promoting cytosolic to mitochondrial translocation, and inducing fission (Marsboom et al., 2012); on the contrary, phosphorylation of Ser-637 retains Drp1 in the cytoplasm (Chang and Blackstone, 2007). Studies have reported that Drp1 is phosphorylated at Ser-637 and dephosphorylated at Ser-616 in starvation conditions (Rambold et al., 2011), while the opposite is true during hyperglycemic conditions (Gawlowski et al., 2012). The inhibition of Drp1 during starvation would lead to fusion and increase mitochondrial respiration (Rambold et al., 2011), supporting the notion that mitochondrial dynamics are linked to the metabolic state of cells (Seo et al., 2020).

Fusion is regulated by GTPases mitofusin 1/2 (MFN1/2) and optic atrophy 1 (OPA1) (Figure 1). Fusion occurs stepwise with mitochondria tethering together first via MFN1/2. Then, the outer mitochondrial membranes fuse as a result of MFN activity (Chen and Chan, 2005). Last, the inner mitochondrial membranes are fused via OPA1 (Cipolat et al., 2004). Studies have reported that MFN1/2 can act redundantly during fusion, and ablation of both results in mitochondrial structural abnormalities and dilated cardiomyopathy in the postnatal heart (Papanicolaou et al., 2012). Postnatally, the heart undergoes rapid proliferation of mitochondria and an increase in respiratory function. Thus, the ablation of both MFNs is lethal in murine models (Papanicolaou et al., 2012) as is the case with homozygous OPA1 mutants (Piquereau et al., 2012). Interestingly, no alteration in mitochondrial respiration was found in mice with a heterozygous OPA1 deletion, but there was mitochondrial network remodeling and increased sensitivity to hemodynamic stress (Piquereau et al., 2012). Ubiquitination of MFNs promotes degradation, which allows for unopposed mitochondrial fission during the removal of damaged mitochondria via mitophagy (Gegg et al., 2010). For mitophagy to occur, mitochondria need to undergo fission, thus inhibition of fusion aids this process. Drp1, on the other hand, was not found to be ubiquitinated during mitophagy as expected (Gegg et al., 2010). The homeostatic balance between fusion and fission is vital for the maintenance of healthy mitochondria in the heart. Similar to “yin and yang,” these opposite and contrary forces are complementary and interconnected, such that dysregulation in either of these processes leads to mitochondrial dysfunction related to cardiac pathologies.

Interestingly, in addition to ER connections, the role of mitochondria has extended to other subcellular membranes. Recent studies have shown that mitochondria can shed mitochondrial-derived vesicles (MDVs) with specific cargoes to the peroxisome or the late-endosome (Neuspiel et al., 2008; Braschi et al., 2010; Soubannier et al., 2012). While these MDVs are distinct from mitophagy-related mechanisms, MDVs have been linked to alterations in cellular physiology and metabolism, although precise mechanisms of action remain largely unknown requiring further investigation.

Calcium Signaling, Apoptosis, and Ferroptosis

Calcium entry in the mitochondria plays an important role in metabolic regulation and cell death mechanisms. A prominent role for mitochondrial calcium entry has been attributed to the mitochondrial calcium uniporter (MCU) complex. Surprisingly, global ablation of MCU has no overt baseline phenotype as these animals had an apparent normal lifespan. While acute mitochondrial calcium entry in the MCU knockout was absent, mitochondrial calcium levels were reduced but existent in mitochondria derived from MCU knockout mice, suggesting the existence of other forms of mitochondrial calcium entry (Pan et al., 2013). Although perhaps moderately speculative, this could be partially attributed to connexin 43 (Cx43), as calcium is permissive through these channels, and Cx43 has been reported to be localized in the mitochondria (Gadicherla et al., 2017). Moreover, the viability of MCU knockout mice depended on the genetic background, as MCU KO was embryonically lethal in C57/BL6 but not in CD1 background (Murphy et al., 2014). Interestingly, cardiac-specific ablation of MCU led to cardioprotection post-I/R (Luongo et al., 2015). Additionally, a variety of proteins have been reported to regulate the MCU complex, among which are spastic paraplegia 7 (SPG7), mitochondrial calcium uptake 1 (MICU1), mitochondrial calcium uniporter 1 (MCUR1), and essential MCU regulator (EMRE) (Mallilankaraman et al., 2012a,b; Shanmughapriya et al., 2015; Vais et al., 2016). Studies over decades have shown that mitochondrial calcium overload can lead to the opening of the mitochondrial permeability transition pore (mPTP) and subsequent cell death. Although mPTP pore function is widely accepted to be vital for cell death mechanisms, the molecular identity of the pore-forming channel remain largely debated. Novel evidence has pointed to an additional function for the F-ATPase, particularly for the c-subunit of the ATPase as the pore-forming channel (Alavian et al., 2015; Urbani et al., 2019). This knowledge has been counter argued by John Walker's group (Nobel Laureate 1997), where persistent permeability transition pore is observed in human mitochondria devoid of assembled ATP synthase (Carroll et al., 2019). For a more extensive review of mitochondrial calcium and its regulators, we defer to another recent review (Garbincius et al., 2020).

Ca²⁺ signaling can occur via a physical connection between the mitochondria and ER, which is thought to be mediated by MFN2 tethering of both organelles (Figure 1) (De Brito and Scorrano, 2008). Nevertheless, there are several controversies surrounding the functional role of MFN2. For instance, reports have shown opposing effects of Mfn2 deficiency in the susceptibility to I/R injury. One study found decreased susceptibility to I/R injury due to delayed mPTP opening from decreased Ca²⁺ intake (Papanicolaou et al., 2011). Another study found increased susceptibility to I/R injury as a result of dysfunctional autophagy and disturbed mitochondrial ultrastructure (Zhao et al., 2012). It is thought that this discrepancy may be due to differences in timing and location as both studies used murine models (Zhao et al., 2012). Moreover, there have been opposing reports on the impact of ablation of Mfn2 on mitochondria–ER junctional distance. One study found the distance between the two organelles to increase by approximately 30% (Chen et al., 2012), while another found no difference in distance (Papanicolaou et al., 2012). It is possible that the discrepancy is due to timing of the Mfn2 gene deletion as the former study ablated Mfn2 during embryonic stages in mice, and the latter ablated Mfn2 after birth in mice (De la Fuente and Sheu, 2019). This is intriguing as it remains unclear how the mitochondria respond to rapid cytosolic Ca²⁺ transients from the ER in contracting cardiac myocytes (Andrienko et al., 2009). Two models describe how cardiac mitochondria interpret Ca²⁺ transients released by the sarcoplasmic reticulum (SR). One model states that mitochondria imports and releases Ca²⁺ with each heartbeat, while the other proposes that mitochondria gradually take up Ca²⁺ until a steady-state environment is reached (Sedova et al., 2006). It is hypothesized that the former model is used in larger animal models relative to mice, while the latter is found mainly in smaller animal models such as mice (Griffiths, 1999). Studies have shown that in addition to Ca²⁺ cycling, cardiac mitochondria are also involved in cellular Ca²⁺ buffering. It was found that in neonatal cardiomyocytes, Ca²⁺ is taken up by the mitochondria in systole and released back into the cytosol during diastole. Between 1% and 15% of cytosolic Ca²⁺ is thought to be buffered by cardiac mitochondria (Drago et al., 2012). Mitochondrial fusion frequency is also coupled with the frequency of Ca²⁺ transient oscillations, rather than sustained transients, and cardiomyocyte contractions (Eisner et al., 2017). In cases where a ryanodine receptor (RyR2) channel mutation is present in murine models, pathologies arise due to altered Ca²⁺ oscillations and inability of cardiomyocytes to contract (Lavorato et al., 2017) linked to fewer fusion events (Eisner et al., 2017). Further studies are needed to expand our understanding on the role of MFN2, ER–mitochondrial Ca²⁺ communication, and susceptibility to cardiac injury.

Mitochondrial Ca²⁺ is an important regulator of cell death. In fact, apoptosis is a major form of cell death in cardiomyocytes that occurs in response to ischemia or metabolic stress linked to decreased ATP levels, dysfunctional electron transport chain (ETC), or excessive oxidative stress. It involves mitochondrial fragmentation, increased mitochondrial permeability caused by Ca²⁺ influx, proapoptotic protein assembly, and cytochrome C release to the cytosol. Pro-apoptotic factors BCL2-interacting protein 3 (BNip3) and BNIP3-like (Nix) form heterodimers with antiapoptotic factors such as B-cell lymphoma—extra large (BclxL) and B-cell lymphoma 2 (Bcl2), which then permit activation of proapoptotic proteins BCL2-associated X (BAX) and BCL2 antagonist killer (BAK). BAX and BAK are pore-forming proteins and increase mitochondrial outer membrane permeability, allowing for the release of cytochrome c into the cytosol and initiation of apoptosis (Gálvez et al., 2006; Dorn, 2010). Apoptosis signaling can be initiated through a secondary pathway when Fis1 on the mitochondrial outer membrane binds to BAP31 on the ER membrane (Iwasawa et al., 2011). Drp1 is not only involved in mitochondrial fission, as it can also promote mitochondrial fragmentation and subsequent apoptotic signaling (Frank et al., 2001). Mitochondrial fragmentation is a component of apoptosis that occurs through mitochondrial fission (Oettinghaus et al., 2016). Nevertheless, Drp1 is not essential for cell death as other proapoptotic proteins can be released in the cytosol to induce apoptosis in the absence of Drp1. Contrarily, Drp1 may induce apoptosis on its own without other proapoptotic proteins (Oettinghaus et al., 2016).

The Bcl-2 family of proteins are paramount regulators of cellular apoptosis. Evidence suggests that these proteins work by decreasing Ca²⁺ release from the ER, increasing IP₃R channel leakage, dampening Ca²⁺ overload in the mitochondria, and mPTP opening probability in response to stress (Bittremieux et al., 2016). mPTP opening dissipates mitochondrial membrane potential, causing swelling and release of proapoptotic factors into the cytoplasm (De Giorgi et al., 2002). Thus, increased mitochondrial Ca²⁺ influx promotes mPTP opening, followed by ATP depletion and cell death (Dorn, 2010).

Ferroptosis is a newly defined form of apoptosis that is dependent on iron. It results from the accumulation of lipid ROS driven by the deficiency of the scavenging antioxidant, glutathione. Iron is used as a catalyst in lipid peroxide-generating reactions; thus, deficiency of ferritin or iron concentration will drive ROS production. Ferroptosis is associated with changes in mitochondrial morphology, such as cristae enlargement and mitochondrial fragmentation. A study using human fibrosarcoma HT1080 cells and mouse embryonic fibroblasts showed that mitochondrial tricarboxylic acid (TCA) cycle and ETC function are essential for potent ferroptosis (Gao et al., 2019). The TCA cycle is required as glutamine, and downstream TCA cycle metabolites are used in the initiation of ferroptosis, while the ETC is necessary to ensure ROS production. Studies were performed in HT1080 cells depleted of mitochondria via Parkin-mediated mitophagy, which caused them to become resistant to ferroptosis (Gao et al., 2019).

Inhibition of ferroptosis has been reported to reduce I/R-related cardiac pathology, protect from cardiomyopathy, and reduce HF incidence (Fang et al., 2019). Heme oxygenase-1 (Hmox1) catalyzes heme degradation, which releases free iron, leading to ferroptosis and HF. Hmox1 is considered to play paradoxical roles on its status as a cardioprotective protein. One study found that Hmox1 can serve a cardioprotective role as overexpression in mice can protect against I/R injury and permanent coronary ligation-induced HF (Wang et al., 2010). On the other hand, another study found that inhibition of Hmox1 in mice is cardioprotective, in a manner that is similar to the effects of iron chelation (Fang et al., 2019). Similarly, a third study showed that overexpression of Hmox1 in murine models leads to spontaneous HF by 1 year of age despite being protected against isoproterenol-induced cardiomyopathy (Allwood et al., 2014). Further studies are required to delineate precise mechanisms of Hmox1 and iron-related cardiac pathologies.

Membrane Contacts and Communication Between Endoplasmic Reticulum and Mitochondria

The mitochondrion has numerous contacts with other organelles such as peroxisomes and the plasma membrane, but the most well-characterized interactions involve ER membranes—an organelle involved in lipid and protein synthesis (Szymański et al., 2017). The peroxisome is an organelle used for oxidation and lipid synthesis, and the plasma membrane is a semipermeable membrane that surrounds the cell. The ultrastructural organization of the contact sites between the mitochondria and ER is termed the mitochondrial–ER contact (MERC), while the collection of proteins and lipids that form the MERC is called the mitochondrial-associated ER membrane (MAM) (Figure 1) (Giacomello and Pellegrini, 2016). An early study using HeLa cells showed that up to 20% of the mitochondrial surface is near ER membranes (Rizzuto et al., 1998). Later on, another study using RBL-2H3 and H9c2 cells proposed that all mitochondria are in contact with the ER (Csordás et al., 2010). While the percentage of ER-mitochondrial membrane contacts remains debatable, it is well-established that the outer membrane of the mitochondria, MAMs, and ER membranes are well-connected, and even the inner membrane of the mitochondria continues to influence pattern, structure, and physiology of adjacent mitochondria (Vincent et al., 2017). Specific proteins have been reported to play a significant role in tethering the ER and mitochondria (Lee and Min, 2018). While some proteins are common to various cellular membranes, others are specific to MAMs.

Although the MERC tethering system has been extensively investigated in yeast and mammalian cells, the exact composition and potential interactions have not been fully characterized (Lee and Min, 2018). In yeast cells, a tethering complex called the ER–mitochondria encounter structure (ERMES) connects the ER to the mitochondrial outer membrane. It is comprised of maintenance of mitochondrial morphology protein 1 (MMM1), mitochondrial disruption and morphology protein 10 (MDM10), mitochondrial disruption and morphology protein 12 (MDM12), and mitochondrial disruption and morphology protein 34 (MDM34) (Kornmann et al., 2009). Specific protein localization via confocal fluorescence microscopy was determined in wild-type and mutant cells that expressed each protein independently. MMM1 was found to be on the ER membrane, MDM10/34 was observed on the mitochondrial outer membrane, and MDM12 was found to be the linker molecule between the two subcellular components (Kornmann et al., 2009).

Mammalian cells lack an ERMES counterpart and are thought to have a more complicated protein interface than yeast cells (Lee and Min, 2018). In mammals, MFN2 is a tethering protein (De Brito and Scorrano, 2008), independent of its role in mitochondrial fusion. Although it is unclear whether MFN2 increases the mito–ER junctional distance, as stated before, cardiac-specific MFN2 knockout studies have led to decreased mitochondrial sensitivity to the SR Ca²⁺ release (Chen et al., 2012; Papanicolaou et al., 2012). The amount of SR-associated RyRs in cardiomyocyte MAMs without MFN2 was significantly lower than wild-type cells despite the overall unchanged cardiac content of RyRs. These effects are either less pronounced or not observed in cells where MFN1 is knocked out (Chen et al., 2012). Nonetheless, in cardiac cells with dual MFN1 and MFN2 ablation, mitochondrial fragmentation, and rapidly lethal dilated cardiomyopathy was observed (Chen et al., 2012).

Other major proteins involved in tethering include vesicle-associated membrane protein-associated protein-B (VAPB), protein tyrosine phosphatase-interacting protein-51 (PTPIP51), glucose-related protein 75 (GRP75), inositol 1,4,5-trisphosphate receptor (IP₃R), voltage-dependent anion channel (VDAC), B-cell receptor-associated protein 31 (BAP31), FIS1, and PDZ domain-containing 8 (PDZD8) (Lee and Min, 2018). In addition to tethering, these proteins play a part in regulating Ca²⁺ buffering, lipid processing, mitochondrial fusion, and autophagy. The abundance, localization, and/or interactions of these proteins often lead to different outcomes, further masking our understanding of this complex process (Lee and Min, 2018). For instance, VAPB is an ER membrane protein, while PTPIP51 is an outer mitochondrial membrane protein. Together, they participate in Ca²⁺ regulation and autophagy. Overexpression of both proteins impairs autophagy and increases mitochondrial Ca²⁺ uptake, while deficiency of both has the opposite effect (Gomez-Suaga et al., 2017). IP₃Rs are located on the ER membrane and facilitate Ca²⁺ efflux toward the mitochondria, while VDAC is situated on the outer mitochondrial membrane and allows for Ca²⁺ influx into the mitochondria. GRP75 is a cytosolic linker that bridges IP₃R and VDAC and promotes delivery of Ca²⁺ into the mitochondria. Cardiac mitochondrial Ca²⁺ uptake is then mediated via the MCU complex in conjunction with VDAC (Szabadkai et al., 2006; Xu et al., 2018). A study analyzing the downregulation of GRP75 in neuronal cells showed reduced ER–mitochondrial coupling and attenuation of Ca²⁺ transfer from the ER to the mitochondria (Honrath et al., 2017). This allowed for mitochondrial resistance to Ca²⁺ overload during oxidative stress. Nevertheless, it remains unclear whether GRP75 inhibition holds potential as a pharmacological target against oxidative stress in cardiomyocytes (Honrath et al., 2017). BAP31 is located on the ER membrane, and FIS1 can be found on the mitochondrial outer membrane. Together, they regulate a secondary pathway for initiation of apoptosis. FIS1 elicits apoptosis signaling via an early and specific caspase-like protease activity that facilitates the cleavage of BAP31 into its proapoptotic form (Iwasawa et al., 2011). This cleavage allows for the recruitment and cleavage of procaspase-8 into caspase-8, a powerful activator of apoptosis. The BAP31–FIS1 complex releases Ca²⁺ downstream from the ER that further amplifies cell death via a positive feedback loop (Iwasawa et al., 2011). PDZD8 is another crucial tethering protein that participates in Ca²⁺ dynamics between the ER and mitochondria. PDZD8 knockdown in neuronal cells significantly decreased mitochondrial Ca²⁺ import despite no change in the Ca²⁺ import machinery, thus implicating the protein in ER–mitochondrial tethering (Hirabayashi et al., 2017). In this latter study, PDZD8 was identified as an ortholog to MMM1 in the yeast ERMES complex, although another study using phylogenetic analyses showed it to be a paralog instead (Wideman et al., 2018).

The ER–mitochondrial tether additionally plays a role in lipid trafficking (Rusiñol et al., 1994). Specific proteins and enzymes involved in lipid synthesis and transfer are enriched in the MAM subdomain of the ER. Examples of these proteins include acyl-coenzyme A cholesterol acyltransferase (ACAT1), phosphatidylserine (PS) synthase, phosphatidylethanolamine N-methyltransferase 2 (PEMT2), fatty acid coenzyme A (CoA) ligase 4 (ACS4), and diacylglycerol O-acyltransferase 2 (DGAT2) (Szymański et al., 2017). ACS4 is used to synthesize acyl CoA used as a precursor for triacylglycerols (TAGs), and DGAT2 catalyzes the final step in TAG synthesis. In a study that examined DGAT2, a known mitochondrial targeting sequence was found in the N-terminus (Stone et al., 2009). MAMs are crucial for the movement of phospholipids between the ER and mitochondria (Hernández-Alvarez et al., 2019). A study using human models of non-alcoholic steatohepatitis and mouse models of non-alcoholic liver disease found decreased levels of Mfn2. In the same study, liver-specific Mfn2 knockout in mouse models resulted in disturbances of ER–mitochondrial PS transfer, revealing a novel mechanism in the development of liver disease (Hernández-Alvarez et al., 2019). Mitochondria import PS synthesized in the ER via PS synthase, which can be decarboxylated into phosphatidylethanolamine (PE). Synthesized PE is able to be exported back to the ER, where it can be methylated via PEMT2 into phosphatidylcholine (PC) (Ridgway and Vance, 1987). ACAT1 catalyzes the synthesis of cholesterol esters, which allows for control of the equilibrium between cytosolic and membrane-bound cholesterol (Puglielli et al., 2001). Cholesterol transfer to the mitochondria from the ER provides material for steroid synthesis. Cholesterol transfer, along with membrane organization and stability, is regulated by caveolin 1 (CAV1), which is abundantly present in MERCs, although its role is controversial. One study using a genetic knockout model found CAV1 to be essential for MERC recruitment and regulation (Sala-Vila et al., 2016), while another study using an inducible CAV1 expression system found CAV1 to cause impairment of MERC communication and remodeling (Bravo-Sagua et al., 2019).

Mitochondrial dynamics are also influenced by MERC tethering, where phospholipid composition of membranes regulates mitochondrial fusion and fission. The main two phospholipids involved are phosphatidic acid (PA) and cardiolipin (CL) (Yu et al., 2020). The de novo mitochondrial synthesis of CL is followed by cycles of CL deacylation and reacylation, which can result in the generation of an array of CL species. Increased exposure of CLs occurs on the outer mitochondrial membrane during mitochondrial stress, where they can serve as binding sites for signaling proteins (Schlame and Haldar, 1993; Osman et al., 2011). CL works in the outer mitochondrial membrane to stimulate pro-fission GTPase Drp1, while PA interacts with Drp1 to inhibit it and promote fusion (Bustillo-Zabalbeitia et al., 2014; Adachi et al., 2016). CL can also promote fusion by interacting with OPA1 on the inner membrane, while PA can stimulate fusion by participating in it with MFN (Choi et al., 2006; Ban et al., 2017).

Role of Mitochondria in Cardiac Health

Mitochondria are the main energy source in cells and are especially important in energy-intensive organs such as the heart. Energy is produced in the form of ATP via oxidative phosphorylation. A balance in the concentration of ATP, adenosine diphosphate (ADP), creatine phosphate (CrP), and inorganic phosphate (Pi) are essential for a healthy heart. In the heart, changes in ATP, ADP, and CrP levels are detected to ensure that transient changes in their levels can cause large heart rate alterations (Balaban et al., 1986). The levels of ATP are thought to be low due to fast turnover and intensive energetic demand (Chistiakov et al., 2018). The enzyme creatine kinase produces phosphocreatine, which is involved in ATP buffering in the myocardium. When there are conditions of high ATP turnover, phosphocreatine concentration is altered to increase oxidative phosphorylation (Bark, 1980). Creatine kinase exists in an octameric form, which is very reactive, and a dimeric form, which is slower. In heart disease, creatine kinase is found predominantly in the slow dimeric form due to disassociation of the octamer. This causes dysfunctional oxidative phosphorylation and less ATP production due to impaired phosphocreatine hydrolysis (Soboll et al., 1999).

The heart obtains over half of its energy from fatty acid oxidation, though it can preferentially utilize glucose instead of lipids depending on energy demands (Ljubkovic et al., 2019). The level of malonyl CoA determines this switch, as increased malonyl CoA levels are associated with increased glucose oxidation and decreased fatty acid oxidation. In the heart, high activity of malonyl CoA decarboxylase (MCD), which converts malonyl CoA to acetyl CoA, maintains cardiac fatty acid substrate preference (Dyck et al., 2004). Studies have proposed that a switch in substrate availability can be altered by insulin signaling (Ljubkovic et al., 2019). In pathologic conditions such as HF or dilated cardiomyopathy, cardiac metabolism shifts toward glucose oxidation under resting conditions. However, under stress, this switch becomes detrimental due to disrupted insulin signaling and inefficient glucose uptake (Neglia et al., 2007).

An efficient mitochondrial ETC uses 98% of the electrons for ATP production (Chistiakov et al., 2018). The small percentage of electrons that escape the ETC and generate superoxide radicals are normally quickly broken down by superoxide dismutase (Boveris et al., 1976). Although the exact mechanism is not fully characterized, a small amount of ROS production can be cardioprotective by triggering protective mechanisms before and after I/R injury (Murry et al., 1986; Zhao et al., 2003). These processes are referred to as preconditioning and postconditioning, respectively. Uncoupling of the ETC results in ROS overproduction and inefficient ATP synthesis. In addition to cellular death, excessive ROS generation can induce atherogenesis through increasing vessel inflammation, oxidized low-density lipoprotein attachment to the vessel wall, endothelial dysfunction, and plaque-induced rupturing (Förstermann et al., 2017).

A healthy heart depends on balanced maintenance of contractile function and constant energy production. Regulation of cellular protein integrity in the heart is termed proteostasis, which involves heat shock response chaperones, autophagy, the ubiquitin–proteasome system, and the unfolded protein response (UPR) (Figure 2) (Arrieta et al., 2020). These processes all act when the mitochondria are under cellular stress. The mitochondrial protein folding environment is complex and the mitochondrial UPR (UPR^mt) is not as well-researched as its counterpart, the ER UPR (UPR^ER) (Li et al., 2019). UPR^ER will be discussed in the next section.

At normal physiological conditions, when UPR^mt is not activated, mitochondrial precursors must be transcribed and translated in the cytoplasm where they are maintained in an unfolded state guided by cytosolic heat shock protein (HSP) chaperones prior to being imported into the mitochondrion, where proteins are then folded (Priesnitz and Becker, 2018). Import stress such as reduced efficiency due to mitochondrial membrane depolarization or mismatch in production of respiratory complex subunits from mtDNA vs. nuclear DNA, leads to the buildup of misfolded or unfolded proteins (Figure 2) (Quirós et al., 2015; Rolland et al., 2019). These unfolded proteins activate the UPR^mt, resulting in the transcription and translation of HSP10/60, and proteases, ATP-dependent Clp protease proteolytic subunit (ClpP) and lon protease homolog 1 (Lon1), to fold the proteins or repair damaged proteins (Martinus et al., 1996; Zhao et al., 2002; Haynes et al., 2007). The initiation of the UPR^mt can occur through two separate pathways. One pathway involves activating transcription factor 5 (ATF5), a transcription factor imported into the mitochondria, where Lon1 and ClpP degrade ATF5 under normal conditions. However, under cellular stress, the accumulation of misfolded proteins in the mitochondria prevents mitochondrial import of ATF5. Decreased mitochondrial import of ATF results in increased Lon1- and ClpP-induced degradation of the misfolded proteins in place of ATF5. The reduced mitochondrial import of ATF5 leads to increased trafficking of ATF5 to the nucleus, resulting in the transcription of UPR-associated proteins, promoting cellular defenses against stress signaling (Nargund et al., 2012; Fiorese et al., 2016). In addition to directly influencing protein translation, Lon1 has been shown to influence transcription indirectly. During activation of UPR^mt, Lon1 degradation of mitochondrial ribonuclease P catalytic subunit (MRPP3) increases MRPP3 turnover, leading to an accumulation of Mrpp3 RNA precursors resulting in impairment of mitochondrial translation (Münch and Harper, 2016). Knockdown of ClpP caused alteration of mitochondrial morphology, excessive ROS production, and a breakdown of oxidative phosphorylation even under non-stressed conditions (Deepa et al., 2016). This study suggested a more global role of ClpP for mitochondrial maintenance than impacting the UPR^mt. The second pathway is initiated by protein kinase RNA-like endoplasmic reticulum kinase (PERK) phosphorylating eukaryotic translation initiation factor 2A (eIF2α), which inhibits protein translation and activates ATF4/5 and C/EBP homologous protein (CHOP) translation. C-Jun N-terminal kinase 2 (JNK2) also binds to the transcription factor C-Jun, which results in the transcription of CHOP. ATF4/5 and CHOP all assist in transcribing other UPR^mt proteins (Aldridge et al., 2007; Baker et al., 2012; Verfaillie et al., 2012). The cumulative effects of both UPR^mt pathways result in reduced overall mitochondrial protein translation and increased translation of specific proteins that assist with refolding or degrading unfolded or misfolded proteins.

Mitophagy is another process that plays a role in proteostasis. Unlike the UPR^mt, which occurs when mitochondria are still salvageable, mitophagy occurs when mitochondria are irreparably damaged (Pickles et al., 2018). Mitophagy is initiated by phosphorylation and mitochondrial recruitment of ubiquitin ligase Parkin by PTEN-induced kinase 1 (PINK1) during stress (Kane et al., 2014). Phosphorylated Parkin recruits autophagy receptors by placing ubiquitin chains on mitochondrial outer membrane proteins (Lazarou et al., 2015). p53-induced inhibition of Parkin exacerbated cardiac aging and dysfunction, suggesting that activation of mitophagy could be a potential target for therapy in diseases related to aging or mitochondrial dysfunction (Hoshino et al., 2013; Pires Da Silva et al., 2020). Interestingly, Drp1—a key protein involved in mitochondrial fission—is also essential for mitophagy. Deficiency of Drp1 resulted in loss of mitophagy, promotion of cardiac dysfunction, and increased susceptibility to I/R injury (Ikeda et al., 2015). Mitophagy is a particularly fascinating topic of research as it is a reparative protective mechanism that may become pathological when uncontrolled.

Alterations in epigenetic regulation are known to promote various pathologies. Recent studies have shown the importance of metabolite diversion from bioenergetic pathways to nuclear epigenetic regulation. Mitochondrial calcium exchange has been shown to participate in myofibroblast activation by promoting shuttling of α-ketoglutarate from the mitochondria to the nucleus where it activates histone demethylases enhancing chromatin accessibility (Lombardi et al., 2019). The concept of retrograde signaling is strongly supported by oncometabolites such as 2-hydroxyglutarate, which are enhanced in gain-of-function mutations in isocitrate dehydrogenases, shown to participate in epigenetic modification of various tumors (Shim et al., 2014). How mitochondrial dynamics may alter retrograde signaling and/or be involved in cellular differentiation as it pertains to cardiac pathologies remain to be fully characterized.

Role of Endoplasmic Reticulum (Sarcoplasmic Reticulum) in Cardiac Health

The ER is the bridge between many different types of membranes and organelles. Important membrane junctions between the ER and other organelles include the ER–endosome (Friedman et al., 2013), ER–peroxisome (Knoblach et al., 2013), ER–Golgi (Peretti et al., 2008), and ER–mitochondria junctions (Shore and Tata, 1977). Along with its extensive contacts, the ER continuity allows other organelles to communicate rapidly via the ER network (Wozniak et al., 2009). A specialized form of the ER exists in cardiomyocytes called the sarcoplasmic reticulum (SR) which acts as a reservoir for Ca²⁺ to facilitate intracellular Ca²⁺ release and storage. Upon depolarization, Ca²⁺ enters the cell and binds to RyRs, which induces calcium-induced Ca²⁺ release (CICR) (Otsu et al., 1990). CICR in the SR is crucial in muscle contraction and relaxation (Terracciano and MacLeod, 1997). Other proteins found in the SR involved in Ca²⁺ signaling include Ca²⁺-ATPases (SERCAs), which work to import Ca²⁺ into the ER and IP₃Rs, which release Ca²⁺ into the cytoplasm along with RyRs (Figure 1) (Nixon et al., 1994). The SR is also the location that controls excitation–contraction coupling in cardiac myocytes (Li et al., 2019). When Ca²⁺ homeostasis becomes dysfunctional, toxic misfolded proteins can accumulate and cause ER stress. Ca²⁺ overload has been proposed to cause protein unfolding and activation of the ER stress response (Wiersma et al., 2017). ER stress has been directly implicated in the progression of atrial fibrillation (AF) (Wiersma et al., 2017).

The ER function comprises protein synthesis, protein folding, Ca²⁺ signaling, and proteostasis during conditions of stress. The ER is the site where proteins imported from cytosolic ribosomes are folded and modified. Proteins that are processed in the ER make up one-third of all synthesized proteins, and they are vital for cardiomyocyte function (Blackwood et al., 2019). A crucial aspect of protein folding is the formation of disulfide bonds, which is catalyzed by combining the protein disulfide isomerase and ER oxidoreductin-1 (PDI-Ero1) complex and an oxidized folding environment (Tu and Weissman, 2002; Araki et al., 2013). ROS is generated as a byproduct of disulfide bond formation during oxidative protein folding, which must be eliminated to maintain ER proteostasis. Any disturbance in redox homeostasis results in ER stress and activation of the UPR^ER response (Figure 2) (Zhang et al., 2019).

The UPR^ER, like the UPR^mt, works in an attempt to mitigate ER stress through three ER membrane-embedded sensors: protein kinase-like ER kinase (PERK), activating transcription factor 6 (ATF6), and inositol-requiring kinase 1 (IRE1) (Senft and Ronai, 2015). The activation of UPR^ER is regulated by the protein BiP, which inactivates the three sensors by binding to them. Binding immunoglobulin protein or heat shock protein family A member 5 (BiP/HSPA5) has a high affinity for misfolded proteins and, in response to their accumulation, will dissociate from PERK, ATF6, and IRE1 (Bertolotti et al., 2000). BiP will then act as a chaperone for the misfolded proteins, while the sensors can activate the three prongs of the ER stress response (Bettigole and Glimcher, 2015). Once ER stress is alleviated, BiP rapidly binds to the sensors again (Bertolotti et al., 2000).

ATF6 acts as a transcription factor via its N-terminus once activated through sites 1 and 2 proteolysis in the Golgi apparatus (Figure 2) (Haze et al., 1999). It works to induce genes in the protein-folding machinery that were previously not thought to play a role in protein folding (Jin et al., 2017). For instance, one study showed that ATF6 had antioxidant properties as it induced catalase activity during I/R conditions. Catalase can neutralize ROS generated as a byproduct of protein folding and protect the heart from I/R injury (Jin et al., 2017). ATF6 has been proposed as a pharmacological therapy since studies showed that selective activation of ATF6 can reduce reperfusion damage and preserve cardiac function (Blackwood et al., 2019). IRE1 activates its ER stress response by splicing X-box-binding protein 1 (Xbp1) mRNA, allowing Xbp1 to become an active transcription factor in the nucleus (Yoshida et al., 2001). Xbp1 contributes to mitigating ER stress by transcribing chaperones and proteins that assist with protein degradation (Lee et al., 2005). It also has transcriptional targets that encompass lipid metabolism (Lee et al., 2005), cellular differentiation (Acosta-Alvear et al., 2007), and elongation of the secretory protein apparatus (Shaffer et al., 2004). In a mouse model of HF with preserved ejection fraction, there was deficiency of IRE1 and Xbp1. However, restoration of Xbp1 ameliorated the phenotype in a disorder with no effective clinical therapies (Schiattarella et al., 2019). PERK acts similarly to its function in the UPR^mt by phosphorylating translation factor eIF2α, which causes massive downregulation of protein translation (Harding et al., 2000). This results in preferential UPR^ER-related protein translation with a global reduction in overall protein translation. ATF4 is a protein that is preferentially translated via this pathway, where it acts as a potent activator of proapoptotic factor CHOP (Dey et al., 2010; Teske et al., 2013). CHOP may be beneficial in mild cases of cardiac ER stress, but during conditions of prolonged ER stress, it is likely harmful (Fu et al., 2010). CHOP-deficient mice had attenuated hypertrophy signs and cardiac dysfunction compared to wild-type mice, suggesting that CHOP could be implicated in the development of cardiac pathology (Fu et al., 2010). Moreover, PERK was cardioprotective in conditions of pressure overload-induced congestive HF (Liu et al., 2014). These studies indicate the complexity of the UPR^ER and showcases that there are instances where it is adaptive, and other cases where it is maladaptive (Arrieta et al., 2020). Hence, mild and short-lived cardiac ER stress may be beneficial to clear unfolded, misfolded, or aged proteins to maintain proper cardiac function. Prolonged ER stress that cannot be quelled, on the other hand, may be detrimental as it can result in apoptosis of cardiac cells. Since cardiomyocytes are terminally differentiated and cannot be largely replenished, excessive apoptosis will lead to cardiac dysfunction resulting in HF (Fang et al., 2019).

Mitochondria and Sarcoplasmic Reticulum Interactions in Cardiac Physiology

The mitochondrion and SR have numerous interactions with each other, which are necessary for healthy cardiac function. Mitochondria are spatially and functionally organized in close contact with the SR. They are tightly associated in areas that support lipid and protein transfer but are more detached in areas of Ca²⁺ delivery (Csordás et al., 2010). This spatial organization contributes to the mitochondrial uptake of Ca²⁺ release from the SR via IP₃Rs, which is essential for mitochondrial ATP production (Figure 1) (Nixon et al., 1994). Ca²⁺ transfer between these two organelles is regulated by MFN2 (De Brito and Scorrano, 2008). Dysfunction of MFN2 and other proteins found in the MAM can alter Ca²⁺ signaling, leading to aberrant signaling that promotes cardiovascular pathogenesis (Chen et al., 2012).

Ca²⁺ is also imperative to excitation–contraction coupling in cardiomyocytes, and research has attempted to elucidate whether mitochondria contribute to cytosolic Ca²⁺ regulation in contracting cardiac cells (Affolter et al., 1976). Recent evidence indicates that mitochondria participate in cardiomyocyte calcium dynamics by interacting with the SR to regulate beat-to-beat phasic calcium cycling. It is known that with every cardiac cycle, Ca²⁺ influx and efflux in the mitochondria occurs, respectively, via the MCU and the Na/Ca²⁺ exchanger (NCLX); nevertheless, the involvement of these processes in regulating excitation–contraction coupling remain largely debated. Recently, the ablation of the mitochondrial NCLX has supported the notion that indeed mitochondrial calcium regulation is vital and participates in cytosolic calcium levels and arrhythmia generation (Luongo et al., 2017). In the following sections, we will briefly describe the role of mito–SR interactions in cardiac hypertrophy, myocardial I/R injury, AF, and diabetic and inherited cardiomyopathy.

Cardiac Hypertrophy and Heart Failure

SR–mitochondria Ca²⁺ dysregulation is thought to be a significant driver in the pathogenesis of cardiac hypertrophy and HF. This could be due to both mitochondrial Ca²⁺ overload and Ca²⁺ deficiency. Mitochondrial Ca²⁺ overload has been shown to promote mPTP opening and ROS generation. In conditions of augmented Ca²⁺ intake, increased ETC activity results in electron leakage and superoxide formation (Zoccarato et al., 2004). The increase in ROS production can lead to posttranslational modification of RyR2, causing the channel to become leaky (Santulli et al., 2015). This results in upregulation of calcium uptake by the mitochondria causing excessive mitochondrial fragmentation, reduction in size, increased permeability of the mPTP pore, and apoptosis initiation. This positive feedback loop of Ca²⁺ influx causes severe mitochondrial loss of function and HF (Santulli et al., 2015). On the other hand, mitochondrial Ca²⁺ deficiency can occur due to increased cytosolic levels of Na⁺. Increased Na⁺ levels cause increased activity of NCLX, resulting in Ca²⁺ efflux from the mitochondria. Reduced Ca²⁺ levels are thought to inhibit TCA cycle activity and increase H₂O₂ levels due to impaired antioxidant capabilities via a reduction in nicotinamide adenine dinucleotide phosphate (NADPH) from slower TCA cycle rates. Furthermore, H₂O₂ can increase Na⁺ current and influx into the mitochondria, amplifying this detrimental feedback loop (Kohlhaas et al., 2010). Inhibition of the NCLX restored Ca²⁺ levels, maintaining mitochondrial redox potential, and replenishing energy supply (Liu and Rourke, 2008). This mechanism is promising in the development of novel pharmacological strategies to treat cardiac hypertrophy and HF.

Excessive adrenergic stimulation can increase the distance between SR–mitochondrial contacts leading to mitochondrial fragmentation, impaired function, and cardiac hypertrophy (Gutiérrez et al., 2014). Norepinephrine increases the distance between the SR and mitochondria in cardiomyocytes, causing inefficient Ca²⁺ transfer (Gutiérrez et al., 2014). The mechanism by which fragmentation occurs is through an increase in Ca²⁺ and calcineurin activation. Calcineurin promotes DRP1-dependent constriction of the mitochondria, whereas the downregulation of calcineurin was shown to inhibit hypertrophy (Pennanen et al., 2014). In addition to alteration in calcineurin signaling, these hypertrophic hearts were also found to have reduced levels of MFN2, resulting in less tethering between the SR and mitochondria and mitochondrial fission (Pennanen et al., 2014). In summary, there is evidence that dysregulation of Ca²⁺ signaling and impairment of mitochondrial dynamics participate in the development of hypertrophy and HF and may be used in the future to develop novel treatment strategies.

Myocardial Infarction and Ischemia/Reperfusion Injury

An MI is defined as the cardiomyocyte death that occurs as a result of prolonged ischemia, while I/R injury describes the tissue damage when perfusion is restored after an ischemic event. Dysfunction in Ca²⁺ transfer and contacts between mitochondria and SR can contribute to cardiac I/R injury. The upregulation of VDAC1, GRP75, and IP₃R channel complex during I/R can lead to Ca²⁺ overload, thus triggering the opening of the mPTP. Once the mPTP pore opens, oxidative stress, mitochondrial swelling, and release of cytochrome c into the cytoplasm ensue leading to cell death (Zhu et al., 2018). Independent downregulation of VDAC1, GRP75, IP₃R, Mfn2, and cyclophilin D (CypD) (mPTP regulator) decreased Ca²⁺ transfer and reduced cell death after I/R injury (Paillard et al., 2013). During I/R, GSK3β activates IP₃R channels via phosphorylation. SB21 inhibition of GSK3β reduces IP₃R channel opening and subsequent mPTP-mediated cell death (Gomez et al., 2016). Administration of sulodexide, a glycosaminoglycan that inhibits ER stress, reduces I/R-induced cellular apoptosis, leading to cardioprotection in murine models (Shen et al., 2019). Activation of the phosphoinositide 3-kinase/protein kinase B (PI₃K/Akt) pathway causes downstream increase in Bcl-2, an antiapoptotic factor, and a decrease in Bax, a proapoptotic factor, thus reducing apoptosis (Shen et al., 2019). It is paramount to fully understand the role of mito–SR communication in ischemic cardiac injury as it may provide novel and unexplored mechanisms that can be explored for new pharmacological interventions.

Atrial Fibrillation

ER stress-induced cardiac remodeling, Ca²⁺ overload, and excessive autophagy are the main drivers of AF. ER stress can occur through deficiency of chaperone proteins, such as HSPA5, whereas alleviation of ER stress can be achieved with the addition of 4PBA, a chemical chaperone. ER stress has also been found to activate mitochondrial apoptosis via the mitogen-activated protein kinase (MAPK) pathway (Shi et al., 2015). Ca²⁺ overload in models of AF has been found to occur through multiple mechanisms. One study using murine models found that the oxidation of RyR2 channels increased intracellular Ca²⁺ release to excessive levels (Xie et al., 2015). Another study using HL-1 atrial cardiomyocytes found that MCU-mediated Ca²⁺ influx enhanced tachypacing-induced mitochondrial dysfunction (Wiersma et al., 2019). Inhibition of this channel via treatment with Ru360 prevented devastating mitochondrial changes. The same study found aberrant ATP levels in models of AF and overexpression of the chaperone HSP60, mitochondrial fragmentation, cardiac remodeling, and contractile dysfunction (Wiersma et al., 2019). Mitochondrial dysfunction is pivotal in the development of AF as it is thought that structural mitochondrial changes exist before AF onset, but AF exacerbates mitochondrial functional impairment, thus promoting a positive feedback loop (Wiersma et al., 2019).

Diabetic and Inherited Cardiomyopathy

ER stress and alterations in the interactions between the ER and mitochondria are crucial in the development of both diabetic and inherited cardiomyopathy. The pathogenesis of diabetic cardiomyopathy stems from impaired insulin signaling resulting in the metabolic switch from glucose metabolism to fatty acid oxidation. There is also decreased activity and presence of β-oxidation enzymes (Ljubkovic et al., 2019). This results in the development of metabolic stress and impaired functional cardiomyocyte efficiency (Ljubkovic et al., 2019). Increased mPTP Ca²⁺ sensitivity and intrinsic caspase-9 signaling are observed in human diabetic cardiomyocytes, presumably due to long-term metabolic stress, leading to an overproduction of mitochondrial ROS (Anderson et al., 2011). In human diabetic heart tissue, there were elevated levels of UPR^ER proteins CHOP and GRP78, linking cardiac diabetes to ER stress processes (Ljubkovic et al., 2019). Compromised cardiac contractility is another feature of diabetic cardiomyopathy, which has been linked to defective Ca²⁺ signaling linked to erratic RyR2 channel behavior (Yaras et al., 2005). ER stress-mediated apoptosis and ROS production in conditions of hyperglycemia have been reported in rats with diabetic cardiomyopathy (Yang et al., 2017). Administration of exogenous H₂S inhibited apoptosis and ER stress via the suppression of hyperglycemia and MFN2-induced oxidative stress (Yang et al., 2017). There is limited evidence linking MERCs and pathogenesis of diabetic CM, but one study found that FUNDC1—an outer mitochondrial membrane protein—levels are elevated in diabetic patients compared to those in nondiabetic patients. It was concluded in the study that diabetes facilitates Fundc1-mediated MERC formation, and inhibition of Fundc1 could be a potential therapy for diabetic CM (Wu et al., 2019).

Inherited cardiomyopathy comprises around 50% of all cases of cardiomyopathy, with the most prevalent forms being dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) (Towbin, 2014; Sacchetto et al., 2019). The most common disease-causing mutation in HCM comes from genes encoding sarcomeric proteins (Singh et al., 2017). The Mybpc3 gene encodes for cardiac myosin-binding protein C (cMyBP-C). A mutation of the Mybpc3 gene in human tissue, and mouse knock-in models supported the notion that autophagy is impaired, whereas activation of autophagy resulted in amelioration of cardiomyopathy (Singh et al., 2017). In DCM patients with S143P mutation in the lamin A/C gene, there was activation of the UPR^ER system as observed by increased ER stress markers (GRP78, IRE1, and ATF6) (Ortega et al., 2014; West et al., 2016). As intraorganellar membrane communication plays a role in many of the processes mentioned above, further understanding of these mechanisms may aid in the development of new pharmacological targets that will, at the very least, delay pathological outcomes.

Therapeutic Targets for Mitochondrial–Endoplasmic Reticulum Interactions

Lifestyle Interventions

Participation in secondary prevention lifestyle changes such as exercise training and caloric restriction has been shown to protect against cardiac risk factors and improve the quality of life of individuals (Clark et al., 2005). Swimming exercise in aged mice suppressed ER stress responses delaying ROS-mediated cell damage by enhancing antioxidation mechanisms via increased superoxide dismutase (Chang et al., 2020). Resistance exercise and aerobic exercise significantly decreased the expression of ER stress markers (CHOP, eIF2α, and PERK) (Kim et al., 2018). Moreover, exercise training was further potentiated when performed concurrently with a lower caloric intake (Kim et al., 2017). This agrees with results showing that caloric restriction delays proteostasis collapse that occurs with cardiac pathogenesis by maintaining robust UPR^ER activity (Matai et al., 2019).

Pharmacological Interventions

Pharmacologic interventions are essential in cases where lifestyle modifications are unable to slow the progression of cardiac disease. They work to restore the balance of the ER–mitochondrial interactions and reduce ER and mitochondrial maladaptive outcomes. The use of 4BPA, a chemical chaperone, which relieves ER stress by reducing misfolded protein aggregation, has been contemplated for the use in cardiac pathologies. 4BPA is available to treat urea cycle disorders and is undergoing human clinical trials for neurological protein misfolding disorders. Thus, this strategy is also under consideration for cardiac diseases, particularly for AF, where autophagosome formation appears to be a hallmark (Wiersma et al., 2017). Another option for intervention is SIRT1, a deacetylase, which has been found to increase beneficial autophagy and decrease ER stress-induced cell death in cardiomyocytes. It promotes autophagy via indirect activation of the eukaryotic elongation factor 2 kinase (eEFK2/eEF2) pathway, possibly through regulation of the acetylation state of eIF2α (Pires Da Silva et al., 2020). The role of beta-blockers in alleviating ER stress in conditions of hypertrophy and HF are also being studied. Beta blockade inhibits beta-adrenergic hyperactivation and drastically reduces ER-mediated apoptosis in cardiomyocytes of hypertrophic and failing hearts (Ni et al., 2011). Last, the administration of taurine, a conditionally essential amino acid, has been implicated in the downregulation of mitochondrial and UPR-dependent cell apoptosis as well as ER stress markers (Yang et al., 2013).

Conclusions

Significant scientific achievements in the twenty-first century have promoted novel pharmacological interventions to maintain cardiac function, yet cardiac disease remains a top cause of death worldwide. Interactions between mitochondria and ER are essential for a healthy myocardium as these processes participate in energy production, apoptosis, ROS management, protein folding, and Ca²⁺ signaling. Disruption in ER or mitochondrial function can play a role in development in hypertrophy, heart failure, myocardial I/R injury, AF, HCM, DCM, and diabetic cardiomyopathy. Several of these pathologies stem from common MERC alterations, but it is unknown why these changes result in different pathologies. Studies further delineating precise mechanisms that regulate intra-organellar membrane communication hold promise to unravel novel therapies that conserve cardiac function by maintaining the ER and mitochondria homeostatic balance and overall cell health.

Author Contributions

VK, AL, and PS reviewed the literature, drafted, and edited the manuscript. VK and JS edited the manuscript and prepared illustrations. AR, SK, AD, and PS reviewed the article and edited the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the American Heart Association 17SDG33660407 (PYS).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References